Developer docs
API playgroundTry for free, no card

Search company profiles

Hers

Full company profile

uuid0008yfz

Namestring
Hers
Legal namestring
Hims & Hers Health, Inc.
Websiteurl
forhers.com
Company typeenum
Public
Founded yearint
2017
Descriptiontext

Hers is a women's telehealth brand and division of Hims & Hers Health, Inc. (NYSE: HIMS), founded in 2017 and headquartered at 2269 Chestnut Street #523, San Francisco. It operates a direct-to-consumer virtual care platform that connects patients in all 50 U.S. states with licensed providers through an asynchronous digital intake flow plus 24/7 in-app messaging, dispensing prescription and OTC products via a network of partner pharmacies (Apostrophe, XeCare, Curexa, Red Rock, AnazaoHealth, Strive) and routing blood draws through 2,000+ Quest Diagnostics locations. Services are cash-pay only, with no insurance accepted for most offerings, and FSA/HSA cards are supported.

The product portfolio spans five primary verticals: (1) GLP-1 weight loss medication access — a membership-gated stack ($39 first month then $149/month) covering Wegovy Pill, Wegovy Pen, Zepbound KwikPen, Zepbound Vial, Foundayo, and Ozempic, leveraging Novo Nordisk's SNAC absorption technology and Eli Lilly's dual GLP-1/GIP and small-molecule oral mechanisms; (2) hair regrowth — topical, oral, and foam minoxidil formulations plus combination supplements; (3) menopause/perimenopause hormone replacement therapy — estradiol pills/patches/vaginal cream and progesterone; (4) preventive health — Labs by Hers subscription at $199/year (Base) or $499/year (Advanced), with 130+ biomarkers, biological age calculation, and an integrated GRAIL Galleri multi-cancer test; and (5) general women's health — birth control, mental health (bupropion, escitalopram, propranolol), sexual wellness, valacyclovir, and prescription skincare. The platform is led by CMO Dr. Jessica Shepherd and supported by an endocrinologist and cardiologist advisor bench; financial scale reached 500,000+ users by late 2025 with an explicit target of surpassing $1 billion in revenue by 2026.

Short descriptiontext

Hers is the women's telehealth division of Hims & Hers Health, Inc. (NYSE: HIMS), offering direct-to-consumer virtual consultations, prescription medications, and lab testing across weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, and preventive screening to women in all 50 U.S. states on a cash-pay basis.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
women's telehealth platform, GLP-1 weight loss medications, prescription hair loss treatment, menopause hormone therapy, direct-to-consumer lab testing
Industry3 codes
1DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription)
CodeHLALAIAAPrimaryYes
2Prescription-Based Digital Clinics (Condition-Specific Rx Programs)
CodeHLALAAADPrimaryNo
3Contraception & Family Planning Telehealth (birth control, counseling, follow-up)
CodeHLALAHABPrimaryNo
NAICS code1 code
  • Other Ambulatory Health Care Services6219
SIC code1 code
  • Services-Health Services8000
Product category
Women's Telehealth / Digital Health
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1Weight Loss Membership
TypeSubscription Recurring
Description

Monthly subscription membership providing access to GLP-1 medications including Wegovy, Zepbound, Foundayo, and Ozempic. Membership includes 24/7 provider messaging, unlimited dosage adjustments, and clinical care. Medication costs billed separately.

desmoinesregister.com
2GLP-1 Medication Sales
TypeSubscription Recurring
Description

Revenue from prescription GLP-1 medications including Wegovy Pill ($149+/month), Wegovy Pen ($199+/month), Zepbound KwikPen ($299/month), Zepbound Vial ($299/month), Ozempic Pill ($149+/month), and Foundayo Pill ($149+/month). Prices vary by medication type and dosage.

desmoinesregister.com
3Lab Testing Subscriptions
TypeSubscription Recurring
Description

Annual subscription-based lab testing service with two tiers: Base Plan at $199/year covering ~50 biomarkers and Advanced Plan at $499/year covering 120+ biomarkers. Includes cancer screening option via Galleri test.

mindbodygreen.com
4Hair Loss Treatment
TypeSubscription Recurring
Description

Revenue from minoxidil-based products (topical solutions, oral minoxidil, hair vitamins, gummies). Products priced around $45 for topical solution. Subscription discounts available.

nypost.com
5Menopause/Hormone Treatment
TypeSubscription Recurring
Description

Prescription hormone replacement therapies including estradiol pills/patches, progesterone pills, and vaginal creams. Costs range from $12/month for birth control to treatments for menopause symptoms.

nypost.com
6Mental Health/Sexual Wellness
TypeSubscription Recurring
Description

Various prescription and OTC products for mental health (bupropion, escitalopram, propranolol) and sexual wellness, sold via subscription model.

nypost.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Marketing or Sales, Supply Chain, Technology or R&D, Operations, Infrastructure
Pricing details12 tiers
1Weight Loss Membership
ModelSubscriptionBilling cadenceMonthly
Notes

$39 for first month, auto-renews at $149/month. Required for GLP-1 prescriptions. Does not include medication costs.

desmoinesregister.com
2Wegovy Pill
ModelSubscriptionBilling cadenceMonthly
Notes

From $149/month. FDA-approved semaglutide pill. Lose up to 20% body weight. Membership required.

forhers.com
3Wegovy Pen
ModelSubscriptionBilling cadenceMonthly
Notes

From $199/month. FDA-approved semaglutide injection. Lose up to 25% body weight. Weekly injection.

forhers.com
4Zepbound KwikPen
ModelSubscriptionBilling cadenceMonthly
Notes

$299/month. FDA-approved tirzepatide injection. Lose up to 21% body weight. Weekly injection.

forhers.com
5Zepbound Vial
ModelSubscriptionBilling cadenceMonthly
Notes

$299/month. FDA-approved tirzepatide injection. Weekly injection.

forhers.com
6Ozempic Pill
ModelSubscriptionBilling cadenceMonthly
Notes

From $149/month. FDA-approved for Type 2 diabetes, may be prescribed off-label for weight loss. Daily pill.

forhers.com
7Foundayo Pill
ModelSubscriptionBilling cadenceMonthly
Notes

From $149/month. FDA-approved orforglipron pill. Lose 11.1% body weight. No food/water restrictions.

forhers.com
8Labs by Hers - Base Plan
ModelSubscriptionBilling cadenceAnnual
Notes

$199/year. Covers approximately 50 biomarkers. Includes initial blood draw (75+ markers) and 6-month retest (55+ markers).

mindbodygreen.com
9Labs by Hers - Advanced Plan
ModelSubscriptionBilling cadenceAnnual
Notes

$499/year (reduced from $349 for promotional pricing). Covers 120+ biomarkers across 10 health categories. Includes cancer screening add-on option.

forhers.com
10Hair Minoxidil Solution
ModelSubscriptionBilling cadenceMonthly
Notes

$45 product (approximately $1.50 per day). FDA-approved 2% minoxidil topical solution. Subscription discounts available.

fortune.com
11Birth Control
ModelSubscriptionBilling cadenceMonthly
Notes

Starting at $12/month. Cash-pay only, no insurance.

nypost.com
12Menopause Treatment
ModelSubscriptionBilling cadenceMonthly
Notes

Includes estradiol pill/patch, progesterone pill, vaginal cream. Feel better in 4-6 weeks. Insurance not required.

forhers.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Labs by Hers
Description

Subscription-based direct-to-consumer lab testing service offering 130+ biomarker tests, cancer screening, and personalized health action plans.

forhers.com
Core offering1 text field

Hers is a women-focused direct-to-consumer telehealth platform that connects patients with licensed healthcare providers via online questionnaires, asynchronous review, and 24/7 messaging. It dispenses FDA-approved prescription medications for weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, birth control, and sexual wellness, and offers subscription-based lab testing (Labs by Hers) processed through Quest Diagnostics. All services are cash-pay with no insurance required, and prescriptions are shipped in discreet packaging through partner pharmacies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Lose up to 25% body weight with Wegovy Pen
+6 more records
Product overview1 text field

Hers is a women-focused multispecialty telehealth platform offering virtual consultations with licensed healthcare providers across all 50 U.S. states on a cash-pay-only basis. The platform provides prescription medications, over-the-counter treatments, and lab testing services for conditions including hair loss, weight management, menopause, mental health, birth control, sexual wellness, and skincare. The core portfolio includes GLP-1 weight loss medications (Wegovy Pill, Wegovy Pen, Zepbound KwikPen, Zepbound Vial, Foundayo Pill, Ozempic Pill) accessible via the Hers Weight Loss Membership; hair regrowth treatments (Minoxidil Topical Solution, Oral Minoxidil, Foam Minoxidil, Hair Vitamins + Minoxidil); menopause hormone replacement therapies (Estradiol Pill/Patch, Estradiol Vaginal Cream, Progesterone Pill); and Labs by Hers for biomarker testing and cancer screening. All services are accessed through the Hers app with discreet medication shipping.

Product and service17 records
1Wegovy Pill
CategoryGLP-1 Weight Loss Medication
Description

FDA-approved once-daily oral GLP-1 medication containing semaglutide for weight loss; clinically proven to help people lose 32 lbs in one year on average using SNAC molecule absorption technology; requires Hers Weight Loss Membership.

2Wegovy Pen
CategoryGLP-1 Weight Loss Medication
Description

FDA-approved once-weekly GLP-1 injection containing semaglutide; clinically proven to help people lose 35 lbs in one year on average; available in dosages from 0.25 mg to 7.2 mg; priced from $199/month.

3Zepbound KwikPen
CategoryGLP-1 Weight Loss Medication
Description

FDA-approved once-weekly GLP-1 injection containing tirzepatide; targets both GLP-1 and GIP receptors; pre-filled pen with 4 doses; lose up to 21% body weight; priced at $299/month.

4Zepbound Vial
CategoryGLP-1 Weight Loss Medication
Description

FDA-approved weekly GLP-1 injection containing tirzepatide in vial form for weight loss; priced at $299/month.

5Foundayo Pill
CategoryGLP-1 Weight Loss Medication
Description

FDA-approved once-daily oral GLP-1 pill containing orforglipron (small-molecule formulation); clinically proven to help lose 11% body weight on average in over a year; no food, water, or timing restrictions; priced from $149/month.

6Ozempic Pill
CategoryGLP-1 Weight Loss Medication
Description

Daily GLP-1 medication containing semaglutide for improving blood sugar levels in adults with Type 2 diabetes; may be prescribed off-label through Hers; priced from $149/month.

7Minoxidil Topical Solution 2%
CategoryHair Loss Treatment
Description

FDA-approved topical 2% minoxidil hair regrowth treatment applied daily; regrows hair in 3-6 months; priced at approximately $45/month.

8Oral Minoxidil
CategoryHair Loss Treatment
Description

Prescription oral minoxidil for hair regrowth; daily pill alternative to topical minoxidil application.

9Hair Vitamins + Minoxidil
CategoryHair Loss Treatment
Description

Combined supplement and topical minoxidil treatment pairing oral hair vitamins with daily minoxidil application.

10Estradiol Pill or Patch
CategoryMenopause Hormone Therapy
Description

FDA-approved hormone replacement therapy in pill or transdermal patch form for postmenopausal women; prescribed off-label for perimenopausal symptoms including hot flashes.

11Estradiol Vaginal Cream
CategoryMenopause Hormone Therapy
Description

Topical vaginal estradiol cream for menopause-related vaginal dryness, itching, and irritation; clinically proven to improve vaginal lining thickness.

12Progesterone Pill
CategoryMenopause Hormone Therapy
Description

Progesterone supplement for menopausal women with a uterus taking estrogen HRT; helps protect the uterine lining.

13Labs by Hers Advanced Plan
CategoryDirect-to-Consumer Lab Testing
Description

Annual subscription-based lab testing service covering 130+ biomarkers across 10 health areas (heart, metabolic, hormone, thyroid, kidney, liver, immune, nutrients, blood); tests twice per year at Quest Diagnostics locations; priced at $499/year after launch pricing.

14Labs by Hers Base Plan
CategoryDirect-to-Consumer Lab Testing
Description

Entry-level annual lab testing subscription covering approximately 50 biomarkers; first draw tests 75+ biomarkers; 6-month retest covers 55+ biomarkers; priced at $199/year.

15Multi-Cancer Test by Galleri
CategoryDirect-to-Consumer Lab Testing
Description

Multi-cancer detection screening test by GRAIL via single blood draw; screens for over 50 cancer types; recommended for adults 50+ or those with elevated cancer risk; processed at CLIA-certified laboratory.

16Birth Control
CategoryWomen's Health Prescription
Description

Telehealth consultations and prescriptions for birth control medications; cash-pay model with no insurance required; costs from $12/month.

17Hers Weight Loss Membership
CategoryWeight Loss Subscription Membership
Description

Monthly subscription membership required to access Hers weight loss medications; includes provider evaluation, 24/7 messaging, unlimited dosage adjustments, peer support community, and exclusive lifestyle brand discounts; first month $39, then $149/month auto-renewing; medication cost billed separately.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-01
Description

CVS Health featured Hers products in Spring Epic Beauty Event promotion (March 1-28, 2026) with markdowns on Hers Minoxidil and other beauty products available both in-store and online.

Strategic tierCoreTypeTechnology or Integration
Description

GRAIL provides the Galleri multi-cancer detection test through Hers Labs. The test screens for 50+ cancer types with a single blood draw. GRAIL clinical laboratory is CLIA-certified and CAP-accredited. GRAIL develops and determines performance characteristics; Hers offers as part of coordinated offering.

Strategic tierCoreTypeTechnology or Integration
Description

Quest Diagnostics processes all Hers lab testing panels. Customers book appointments at 2,000+ Quest locations nationwide through the Hers app. Quest provides the blood draw infrastructure for Hers Labs by Hers biomarker testing.

Strategic tierCoreTypeTechnology or Integration
Description

Novo Nordisk manufactures Wegovy (semaglutide) and Ozempic (semaglutide). Hers offers these FDA-approved GLP-1 medications through its telehealth platform. Novo Nordisk developed SNAC molecule technology for oral semaglutide absorption.

Strategic tierCoreTypeTechnology or Integration
Description

Eli Lilly manufactures Zepbound (tirzepatide) and Foundayo (orforglipron). Hers offers these FDA-approved GLP-1 medications through its platform. Zepbound targets both GLP-1 and GIP receptors. Foundayo is a trademark of Eli Lilly.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Primary pharmacy fulfillment partner for Hers prescriptions. One of several pharmacies that fill prescriptions ordered through the Hers platform. Prescriptions may be transferred between partner pharmacies.

7XeCare LLC
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Pharmacy fulfillment partner for Hers prescription medications. Part of the pharmacy network that fills and ships prescriptions to customers.

forhers.com
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Pharmacy fulfillment partner (dba Curexa) for Hers prescriptions. Part of the pharmacy network handling prescription fulfillment and shipping.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Utah-based pharmacy fulfillment partner for Hers prescriptions. Part of the pharmacy network that fills and ships medications.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Pharmacy fulfillment partner for Hers prescriptions. Part of the network handling prescription fulfillment and direct shipping to customers.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Pharmacy fulfillment partner for Hers prescriptions and its affiliates. Part of the prescription fulfillment network.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Multiple medical groups including You Health of Alaska, California, Hawaii, Kansas, Nebraska, Nevada, New Jersey, and Texas P.C. These employ or contract with physicians and healthcare providers who offer clinical services through the Hers platform.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Gifthealth provides access to manufacturer self-pay pharmacy solutions programs for certain weight loss prescriptions not available through Hers' primary pharmacy partners. Independent third-party pharmacy enabling broader medication access.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Exclusive discount partners for Hers Weight Loss members. Provides lifestyle support through meal delivery, fitness tracking, and athletic wear discounts.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The Pill Club is a telehealth birth control delivery service, directly competing with Hers' contraception offering through a similar online prescribing and pharmacy fulfillment model.

TypeDirect peer
Description

Nurx is a telehealth provider specializing in women's health, including birth control, STI testing, and herpes treatment — overlapping directly with Hers' birth control, mental health, and sexual wellness offerings.

TypeDirect peer
Description

Found is a telehealth weight-loss platform focused on GLP-1 prescriptions and metabolic care — a direct competitor to Hers' weight loss membership with similar cash-pay, GLP-1-centric positioning.

4Ro
TypeDirect peer
Description

Ro is a direct-to-consumer telehealth platform offering cash-pay virtual care across men's and women's health, including weight loss, sexual health, and hair loss — the closest comparable to Hers' cash-pay, DTC, multi-condition model.

TypeDirect peer
Description

Tia is a women's healthcare provider combining virtual and in-person care across primary care, gynecology, and mental health — competing with Hers on the women's health platform category with a hybrid care delivery model.

TypeBroad incumbent
Description

Noom is a digital weight-loss platform combining behavior-change coaching with an increasingly prominent GLP-1 telehealth offering — a broader incumbent that overlaps with Hers' weight-loss category at a larger scale.

TypeDirect peer
Description

Maven Clinic is a virtual care platform focused on women's and family health covering fertility, pregnancy, postpartum, and menopause — a direct competitor in the women-focused telehealth category with strong employer and payer contracts.

TypeBroad incumbent
Description

Teladoc Health is a large public telehealth incumbent offering virtual care across many specialties including mental health, dermatology, and chronic care — a broad incumbent that competes with Hers in DTC virtual care, though with a B2B and payer-led model rather than cash-pay DTC.

TypeDirect peer
Description

Hims is Hers' sister brand under Hims & Hers Health, offering the men's health equivalent of Hers' portfolio — identical business model, platform, pharmacy network, and membership mechanics, but targeted at men.

TypeBroad incumbent
Description

WW is the legacy weight-loss incumbent that has expanded into GLP-1 telehealth through its WeightWatchers Clinic offering — a broad incumbent now competing directly with Hers in cash-pay, GLP-1-supported weight management.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hers

Women's Telehealth / Digital Healthforhers.com

Hers is the women's telehealth division of Hims & Hers Health, Inc. (NYSE: HIMS), offering direct-to-consumer virtual consultations, prescription medications, and lab testing across weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, and preventive screening to women in all 50 U.S. states on a cash-pay basis.

What Hers does

Hers is a women's telehealth brand and division of Hims & Hers Health, Inc. (NYSE: HIMS), founded in 2017 and headquartered at 2269 Chestnut Street #523, San Francisco. It operates a direct-to-consumer virtual care platform that connects patients in all 50 U.S. states with licensed providers through an asynchronous digital intake flow plus 24/7 in-app messaging, dispensing prescription and OTC products via a network of partner pharmacies (Apostrophe, XeCare, Curexa, Red Rock, AnazaoHealth, Strive) and routing blood draws through 2,000+ Quest Diagnostics locations. Services are cash-pay only, with no insurance accepted for most offerings, and FSA/HSA cards are supported.

The product portfolio spans five primary verticals: (1) GLP-1 weight loss medication access — a membership-gated stack ($39 first month then $149/month) covering Wegovy Pill, Wegovy Pen, Zepbound KwikPen, Zepbound Vial, Foundayo, and Ozempic, leveraging Novo Nordisk's SNAC absorption technology and Eli Lilly's dual GLP-1/GIP and small-molecule oral mechanisms; (2) hair regrowth — topical, oral, and foam minoxidil formulations plus combination supplements; (3) menopause/perimenopause hormone replacement therapy — estradiol pills/patches/vaginal cream and progesterone; (4) preventive health — Labs by Hers subscription at $199/year (Base) or $499/year (Advanced), with 130+ biomarkers, biological age calculation, and an integrated GRAIL Galleri multi-cancer test; and (5) general women's health — birth control, mental health (bupropion, escitalopram, propranolol), sexual wellness, valacyclovir, and prescription skincare. The platform is led by CMO Dr. Jessica Shepherd and supported by an endocrinologist and cardiologist advisor bench; financial scale reached 500,000+ users by late 2025 with an explicit target of surpassing $1 billion in revenue by 2026.

Hers firmographics

Firmographics
Name
Hers
Legal name
Hims & Hers Health, Inc.
Website
https://forhers.com
Company type
Public
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Hers is the women's telehealth division of Hims & Hers Health, Inc. (NYSE: HIMS), offering direct-to-consumer virtual consultations, prescription medications, and lab testing across weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, and preventive screening to women in all 50 U.S. states on a cash-pay basis.
Ownership category
akta.pro rank

Hers industry classification

Industry
Product category
Women's Telehealth / Digital Health
NAICS
Other Ambulatory Health Care Services (6219)
SIC
Services-Health Services (8000)
akta.pro primary industry
DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
akta.pro secondary industries
Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), Contraception & Family Planning Telehealth (birth control, counseling, follow-up) (HLALAHAB)

Keywords

  • Women's telehealth platform
  • GLP-1 weight loss medications
  • Prescription hair loss treatment
  • Menopause hormone therapy
  • Direct-to-consumer lab testing

Where Hers is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Hers business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Marketing or Sales, Supply Chain, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Weight Loss Membership: Monthly subscription membership providing access to GLP-1 medications including Wegovy, Zepbound, Foundayo, and Ozempic. Membership includes 24/7 provider messaging, unlimited dosage adjustments, and clinical care. Medication costs billed separately.
  2. GLP-1 Medication Sales: Revenue from prescription GLP-1 medications including Wegovy Pill ($149+/month), Wegovy Pen ($199+/month), Zepbound KwikPen ($299/month), Zepbound Vial ($299/month), Ozempic Pill ($149+/month), and Foundayo Pill ($149+/month). Prices vary by medication type and dosage.
  3. Lab Testing Subscriptions: Annual subscription-based lab testing service with two tiers: Base Plan at $199/year covering ~50 biomarkers and Advanced Plan at $499/year covering 120+ biomarkers. Includes cancer screening option via Galleri test.
  4. Hair Loss Treatment: Revenue from minoxidil-based products (topical solutions, oral minoxidil, hair vitamins, gummies). Products priced around $45 for topical solution. Subscription discounts available.
  5. Menopause/Hormone Treatment: Prescription hormone replacement therapies including estradiol pills/patches, progesterone pills, and vaginal creams. Costs range from $12/month for birth control to treatments for menopause symptoms.
  6. Mental Health/Sexual Wellness: Various prescription and OTC products for mental health (bupropion, escitalopram, propranolol) and sexual wellness, sold via subscription model.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyWeight Loss Membership
SubscriptionMonthlyWegovy Pill
SubscriptionMonthlyWegovy Pen
SubscriptionMonthlyZepbound KwikPen
SubscriptionMonthlyZepbound Vial
SubscriptionMonthlyOzempic Pill
SubscriptionMonthlyFoundayo Pill
SubscriptionAnnualLabs by Hers - Base Plan
SubscriptionAnnualLabs by Hers - Advanced Plan
SubscriptionMonthlyHair Minoxidil Solution
SubscriptionMonthlyBirth Control
SubscriptionMonthlyMenopause Treatment

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Hers product offering

Product offering

Core offering

Hers is a women-focused direct-to-consumer telehealth platform that connects patients with licensed healthcare providers via online questionnaires, asynchronous review, and 24/7 messaging. It dispenses FDA-approved prescription medications for weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, birth control, and sexual wellness, and offers subscription-based lab testing (Labs by Hers) processed through Quest Diagnostics. All services are cash-pay with no insurance required, and prescriptions are shipped in discreet packaging through partner pharmacies.

Product overview

Hers is a women-focused multispecialty telehealth platform offering virtual consultations with licensed healthcare providers across all 50 U.S. states on a cash-pay-only basis. The platform provides prescription medications, over-the-counter treatments, and lab testing services for conditions including hair loss, weight management, menopause, mental health, birth control, sexual wellness, and skincare. The core portfolio includes GLP-1 weight loss medications (Wegovy Pill, Wegovy Pen, Zepbound KwikPen, Zepbound Vial, Foundayo Pill, Ozempic Pill) accessible via the Hers Weight Loss Membership; hair regrowth treatments (Minoxidil Topical Solution, Oral Minoxidil, Foam Minoxidil, Hair Vitamins + Minoxidil); menopause hormone replacement therapies (Estradiol Pill/Patch, Estradiol Vaginal Cream, Progesterone Pill); and Labs by Hers for biomarker testing and cancer screening. All services are accessed through the Hers app with discreet medication shipping.

Differentiator

Problem solved

Functional benefit

Brands

  • Labs by Hers: Subscription-based direct-to-consumer lab testing service offering 130+ biomarker tests, cancer screening, and personalized health action plans.

Products and services

  • Wegovy Pill FDA-approved once-daily oral GLP-1 medication containing semaglutide for weight loss; clinically proven to help people lose 32 lbs in one year on average using SNAC molecule absorption technology; requires Hers Weight Loss Membership.
  • Wegovy Pen FDA-approved once-weekly GLP-1 injection containing semaglutide; clinically proven to help people lose 35 lbs in one year on average; available in dosages from 0.25 mg to 7.2 mg; priced from $199/month.
  • Zepbound KwikPen FDA-approved once-weekly GLP-1 injection containing tirzepatide; targets both GLP-1 and GIP receptors; pre-filled pen with 4 doses; lose up to 21% body weight; priced at $299/month.
  • Zepbound Vial FDA-approved weekly GLP-1 injection containing tirzepatide in vial form for weight loss; priced at $299/month.
  • Foundayo Pill FDA-approved once-daily oral GLP-1 pill containing orforglipron (small-molecule formulation); clinically proven to help lose 11% body weight on average in over a year; no food, water, or timing restrictions; priced from $149/month.
  • Ozempic Pill Daily GLP-1 medication containing semaglutide for improving blood sugar levels in adults with Type 2 diabetes; may be prescribed off-label through Hers; priced from $149/month.
  • Minoxidil Topical Solution 2% FDA-approved topical 2% minoxidil hair regrowth treatment applied daily; regrows hair in 3-6 months; priced at approximately $45/month.
  • Oral Minoxidil Prescription oral minoxidil for hair regrowth; daily pill alternative to topical minoxidil application.
  • Hair Vitamins + Minoxidil Combined supplement and topical minoxidil treatment pairing oral hair vitamins with daily minoxidil application.
  • Estradiol Pill or Patch FDA-approved hormone replacement therapy in pill or transdermal patch form for postmenopausal women; prescribed off-label for perimenopausal symptoms including hot flashes.
  • Estradiol Vaginal Cream Topical vaginal estradiol cream for menopause-related vaginal dryness, itching, and irritation; clinically proven to improve vaginal lining thickness.
  • Progesterone Pill Progesterone supplement for menopausal women with a uterus taking estrogen HRT; helps protect the uterine lining.
  • Labs by Hers Advanced Plan Annual subscription-based lab testing service covering 130+ biomarkers across 10 health areas (heart, metabolic, hormone, thyroid, kidney, liver, immune, nutrients, blood); tests twice per year at Quest Diagnostics locations; priced at $499/year after launch pricing.
  • Labs by Hers Base Plan Entry-level annual lab testing subscription covering approximately 50 biomarkers; first draw tests 75+ biomarkers; 6-month retest covers 55+ biomarkers; priced at $199/year.
  • Multi-Cancer Test by Galleri Multi-cancer detection screening test by GRAIL via single blood draw; screens for over 50 cancer types; recommended for adults 50+ or those with elevated cancer risk; processed at CLIA-certified laboratory.
  • Birth Control Telehealth consultations and prescriptions for birth control medications; cash-pay model with no insurance required; costs from $12/month.
  • Hers Weight Loss Membership Monthly subscription membership required to access Hers weight loss medications; includes provider evaluation, 24/7 messaging, unlimited dosage adjustments, peer support community, and exclusive lifestyle brand discounts; first month $39, then $149/month auto-renewing; medication cost billed separately.

Quantifiable outcome

  • Lose up to 25% body weight with Wegovy Pen
  • +6 more outcomes

Companies that use Hers

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Hers technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Hers partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered minor and core.

  • CVS HealthminorChannel Partner/ Reseller/ Distributor · 1 March 2026CVS Health featured Hers products in Spring Epic Beauty Event promotion (March 1-28, 2026) with markdowns on Hers Minoxidil and other beauty products available both in-store and online.
  • GRAIL, Inc.coreTechnology or IntegrationGRAIL provides the Galleri multi-cancer detection test through Hers Labs. The test screens for 50+ cancer types with a single blood draw. GRAIL clinical laboratory is CLIA-certified and CAP-accredited. GRAIL develops and determines performance characteristics; Hers offers as part of coordinated offering.
  • Quest Diagnostics IncorporatedcoreTechnology or IntegrationQuest Diagnostics processes all Hers lab testing panels. Customers book appointments at 2,000+ Quest locations nationwide through the Hers app. Quest provides the blood draw infrastructure for Hers Labs by Hers biomarker testing.
  • Novo Nordisk A/ScoreTechnology or IntegrationNovo Nordisk manufactures Wegovy (semaglutide) and Ozempic (semaglutide). Hers offers these FDA-approved GLP-1 medications through its telehealth platform. Novo Nordisk developed SNAC molecule technology for oral semaglutide absorption.
  • Eli Lilly and CompanycoreTechnology or IntegrationEli Lilly manufactures Zepbound (tirzepatide) and Foundayo (orforglipron). Hers offers these FDA-approved GLP-1 medications through its platform. Zepbound targets both GLP-1 and GIP receptors. Foundayo is a trademark of Eli Lilly.
  • Apostrophe Pharmacy LLCcoreImplementation/ SI/ Consulting PartnerPrimary pharmacy fulfillment partner for Hers prescriptions. One of several pharmacies that fill prescriptions ordered through the Hers platform. Prescriptions may be transferred between partner pharmacies.
  • XeCare LLCcoreImplementation/ SI/ Consulting PartnerPharmacy fulfillment partner for Hers prescription medications. Part of the pharmacy network that fills and ships prescriptions to customers.
  • Curexa (EHT Pharmacy LLC)coreImplementation/ SI/ Consulting PartnerPharmacy fulfillment partner (dba Curexa) for Hers prescriptions. Part of the pharmacy network handling prescription fulfillment and shipping.
  • Red Rock Pharmacy (CD Pharmacy LLC)coreImplementation/ SI/ Consulting PartnerUtah-based pharmacy fulfillment partner for Hers prescriptions. Part of the pharmacy network that fills and ships medications.
  • AnazaoHealth CorporationcoreImplementation/ SI/ Consulting PartnerPharmacy fulfillment partner for Hers prescriptions. Part of the network handling prescription fulfillment and direct shipping to customers.
  • Strive Specialties, Inc.coreImplementation/ SI/ Consulting PartnerPharmacy fulfillment partner for Hers prescriptions and its affiliates. Part of the prescription fulfillment network.
  • Medical Groups (You Health)coreImplementation/ SI/ Consulting PartnerMultiple medical groups including You Health of Alaska, California, Hawaii, Kansas, Nebraska, Nevada, New Jersey, and Texas P.C. These employ or contract with physicians and healthcare providers who offer clinical services through the Hers platform.
  • Gifthealth, Inc.minorChannel Partner/ Reseller/ DistributorGifthealth provides access to manufacturer self-pay pharmacy solutions programs for certain weight loss prescriptions not available through Hers' primary pharmacy partners. Independent third-party pharmacy enabling broader medication access.
  • HelloFresh, MyFitnessPal, LadderminorGTM or Marketing PartnerExclusive discount partners for Hers Weight Loss members. Provides lifestyle support through meal delivery, fitness tracking, and athletic wear discounts.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Hers competitors and assessment

Company assessment

Direct peers

  • The Pill Club: The Pill Club is a telehealth birth control delivery service, directly competing with Hers' contraception offering through a similar online prescribing and pharmacy fulfillment model.
  • Nurx: Nurx is a telehealth provider specializing in women's health, including birth control, STI testing, and herpes treatment — overlapping directly with Hers' birth control, mental health, and sexual wellness offerings.
  • Found: Found is a telehealth weight-loss platform focused on GLP-1 prescriptions and metabolic care — a direct competitor to Hers' weight loss membership with similar cash-pay, GLP-1-centric positioning.
  • Ro: Ro is a direct-to-consumer telehealth platform offering cash-pay virtual care across men's and women's health, including weight loss, sexual health, and hair loss — the closest comparable to Hers' cash-pay, DTC, multi-condition model.
  • Tia: Tia is a women's healthcare provider combining virtual and in-person care across primary care, gynecology, and mental health — competing with Hers on the women's health platform category with a hybrid care delivery model.
  • Maven Clinic: Maven Clinic is a virtual care platform focused on women's and family health covering fertility, pregnancy, postpartum, and menopause — a direct competitor in the women-focused telehealth category with strong employer and payer contracts.
  • Hims: Hims is Hers' sister brand under Hims & Hers Health, offering the men's health equivalent of Hers' portfolio — identical business model, platform, pharmacy network, and membership mechanics, but targeted at men.

Broad incumbents

  • Noom: Noom is a digital weight-loss platform combining behavior-change coaching with an increasingly prominent GLP-1 telehealth offering — a broader incumbent that overlaps with Hers' weight-loss category at a larger scale.
  • Teladoc Health: Teladoc Health is a large public telehealth incumbent offering virtual care across many specialties including mental health, dermatology, and chronic care — a broad incumbent that competes with Hers in DTC virtual care, though with a B2B and payer-led model rather than cash-pay DTC.
  • WW International (WeightWatchers): WW is the legacy weight-loss incumbent that has expanded into GLP-1 telehealth through its WeightWatchers Clinic offering — a broad incumbent now competing directly with Hers in cash-pay, GLP-1-supported weight management.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Hers social profiles

Digital presence

Hers financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hers leadership team

Management profile

Number of profiles

Profiles5 records

Hers funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hers M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hers

What does Hers do?

Hers is a women-focused direct-to-consumer telehealth platform that connects patients with licensed healthcare providers via online questionnaires, asynchronous review, and 24/7 messaging. It dispenses FDA-approved prescription medications for weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, birth control, and sexual wellness, and offers subscription-based lab testing (Labs by Hers) processed through Quest Diagnostics. All services are cash-pay with no insurance required, and prescriptions are shipped in discreet packaging through partner pharmacies.

Is Hers a public or private company?

Hers is a public company. It is classified as public and is currently operating.

When was Hers founded?

Hers was founded in 2017. It employs 101 to 250 people.

Where is Hers based?

Hers is headquartered in San Francisco, United States, in the North America region.

How does Hers make money?

Six revenue lines are on record. Weight Loss Membership is the primary driver. The others are GLP-1 Medication Sales, lab Testing Subscriptions, hair Loss Treatment, menopause/Hormone Treatment and mental Health/Sexual Wellness.

Who are Hers's main competitors?

Direct peers on record are The Pill Club, Nurx, Found, Ro, Tia, Maven Clinic and Hims. Broad incumbents are Noom, Teladoc Health and WW International (WeightWatchers).

Does Hers have an API?

No public API is recorded for Hers.

What industry is Hers in?

Hers's product category is Women's Telehealth / Digital Health. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs). Its NAICS code is 6219 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Des Moines RegisterCan Hers help with hair loss? Treatments, costs and timeline explainedHers offers online consultations with licensed providers for women's hair loss, providing prescription and non-prescription treatments like minoxidil and vitamins. Plans start at $15 per month, with results taking three to six months. Some treatments require a prescription, while others are over-the-counter.The Asheville Citizen TimesCan Hers help with hair loss? Treatments, costs and timeline explainedHers offers online consultations and hair-loss treatments starting at $15 per month, including prescription and non-prescription options like minoxidil and vitamins. Results may take three to six months, and some treatments require a prescription from a licensed provider.The Des Moines RegisterHers launches a weight loss membership starting at just $39Hers, a telehealth platform for women, launched a weight loss membership program offering access to GLP-1 medications through virtual consultations with licensed providers. The program starts at $39 for the first month, $149 thereafter, and includes 24/7 messaging, a Care Team, dosage adjustments, and lifestyle tools. Prescribed medications range from oral options to branded injections like Ozempic and Wegovy, with costs varying by treatment.TechBullionTWL Review 2026: How Its Online Weight-Loss Provider Rankings Work and What Patients Should CompareA review of Top Weight Loss Med, or TWL, describes its virtual healthcare platform and its published comparison of online GLP-1 weight-loss providers. At the time of the review, TWL ranked Zealthy 9.9, Bioverse 9.8, FitRx 9.7, AM Rx 9.6 and Hers 8.9, though the scoring methodology is not disclosed. The article advises patients to compare insurance support, pricing, medication type, pharmacy fulfillment and coaching rather than relying on the scores.TechTargetHims & Hers upgrades women's health app with AI, smart scale integrationHims & Hers upgraded its Hers app with AI-driven tracking and a smart scale that syncs weight metrics. The features are first available to weight-loss members, then to other categories. The company aims to integrate AI into its infrastructure.RoRo vs. Hers for weight loss 2026: a comparison guideRo and Hers both offer FDA-approved GLP-1 weight loss medications via telehealth, but Ro provides insurance concierge and lower costs. Ro's membership can be as low as $74 per month with prepaid plans, while Hers costs $149 monthly. Ro collaborates with Eli Lilly and Novo Nordisk, whereas Hers only with Novo Nordisk.The Des Moines RegisterI lost 80 pounds on a GLP‑1—Hers is making treatment more accessibleHers, a women-focused telehealth brand, has launched a new monthly GLP-1 weight loss membership program designed to improve accessibility to weight loss medications. The program starts at $39 for the first month and $149 per month thereafter, including 24/7 provider messaging, unlimited dosage adjustments, and access to treatments such as Ozempic and Wegovy, with medication costs billed separately. The launch positions Hers to capture demand from consumers priced out of traditional GLP-1 care, expanding its footprint in the virtual weight loss market.FortuneHers Hair Growth Review (2026)Fortune published a hands-on review of Hers Women's Minoxidil 2% Topical Solution, rating the product 4 out of 5 after testing its ease of use, packaging, smell, texture, and product support over an early period of use. The $45 product (approximately $1.50 per day) received praise for its FDA approval, clear directions, and science-backed active ingredient (Minoxidil 2%), though the reviewer noted a slight rubbing alcohol smell and the cost without subscription discounts as drawbacks. The article contextualizes that women comprise 40 percent of hair loss sufferers in the United States, according to the American Hair Loss Association, and compares Hers against competing products including Nutrafol, Happy Head, and Rogaine.SELFFor Some Women, Weight Loss Drugs Are a Secret They Keep From Their PartnersA growing number of women using GLP-1 weight loss medications like Wegovy are keeping their prescriptions secret from partners and family members, going to elaborate lengths to hide the drugs in everyday household containers. Telemedicine platforms such as Hers and Ro have made it easier to obtain these medications without informing a primary care physician, raising medical concerns about undisclosed drug interactions and pregnancy risks. Healthcare providers note that while secrecy can be empowering for patients controlling their own narrative, hiding medication can also increase stress and complicate medical care.